ReviewJournal of personalized medicine2021

Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Look at the Approved and Emerging Therapies.

Yazeed SawalhaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.